Approval · Notice of Compliance 24654 · 2020
VALPROIC ACID: Notice of Compliance 24654
Issued November 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24654
- Date
- November 20, 2020
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership. update the pm to be in line with crp pm. update to inner and outer labels
- Canadian reference product
- DEPAKANE (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALPROIC ACID | 02237830 | Approved |
| VALPROIC ACID | Not yet assigned | — |
| VALPROIC ACID ORAL SOLUTION | 02238069 | Approved |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 250 MG per 5ML